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Introduction:The antineoplastic Anthracyclines are effective agents for various tumors, 
there is a dose-response relationship for these drugs, however, cardiotoxicity limits 
their therapeutic potential and threaten the cardiac function of patients. 
The mechanism of the onset of cardiotoxicity is still not clarified, the most common 
hypothesis is related to the triggering mechanisms of programmed death - apoptosis - 
that promote various morphological and biochemical changes in cells. A very early 
stage, there is the exposure of phosphatidylserine, a phospholipid that in healthy cells 
remains in the inner leaflet of the plasma membrane. 
This exhibition may be marked through radioactive molecules, as is the case of 99mTc-
Annexin V, the Annexin V is an endogenous human protein, distributed intracellularly, 
with high affinity for phosphatidylserine. 
 
Objectives: Currently there are various techniques for evaluation of cardiotoxicity, 
although these have several limitations, such as invasiveness or the late response, so 
that there is a need to develop non-invasive techniques and enabling the achievement 
of results as early as possible. 
The purpose of this study is to deepen the role and importance of Nuclear Imaging 
using 99mTc-Annexin in the context of early evaluation of cardiotoxicity.  
 
Material and Methods: This study consists of a literature review that discusses the 
radiolabeled tracer techniques, studies in vivo and in vitro and its impact on clinical 
practice and treatment of patients. 
 Conclusions: It wiil prove that, due to changes that occur in the cell during apoptosis 
and the high affinity of Annexin V with phosphatidylserine, using the 99mTc-Annexin V, 
Nuclear Medicine Imaging allows access to early diagnosis of cardiotoxicity, thus 
allowing the establishment of new chemotherapeutic regimens, more appropriate, 
more specific and clearly customized to the patient subject to assessment, thereby 
contributing to a better prognosis of the same.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Foi decidido que não será apresentada a versão integral deste 
documento. 
Para obtenção de mais informações: 
www.nucmedonline.net 
cursomedicinanuclear@gmail.com 
 
 
 
It has been decided that it would not be shown the entire version 
of this document. 
To obtain more informations: 
www.nucmedonline.net 
cursomedicinanuclear@gmail.com 
 
 
